Citations

Mayo Clinic

Showing 10 of 108572 citations.

Artificial Intelligence Evaluation of Stool Quality Guides Management of Hepatic Encephalopathy Using a Smartphone App
Fagan, Andrew , Gallagher, Mary Leslie, Mousel, Travis, Davis, Brian , Puri, Puneet, Anstey, Jacob, Tiede, David, Kraus, Asaf, Bajaj, Jasmohan S. , Bajaj, Jasmohan S , Fuchs, Michael A. , Puri, Puneet, Simonetto, Douglas A.

American Journal of Gastroenterology | December 28, 2023 | Volume: 119 | Issue: 5 | Pages: 977-981

10.14309/ajg.0000000000002646 | PMID 38153339 Get It

Lactulose-based hepatic encephalopathy treatment requires bowel movements/day titration, which is improved with Bristol stool scale (BSS) incorporation. Dieta app evaluates artificial intelligence (AI)-based BSS (AI-BSS) with stool images. Initially, controls (N = 13) and cirrhosis patients on lactulose/not on lactulose (n = 33) were trained on the app. They entered self-reported BSS (self-BSS) with AI-BSS communicated. Lactulose dose changes were tracked. A subset (n = 12) was retested with AI communication blocked. Most subjects were comfortable with the app. Self/AI-BSS and lactulose dose/AI-BSS correlation increased with app use. AI-BSS communications improved insight into self-BSS over time. Dieta app to gauge stool AI characteristics was acceptable and increased insight into lactulose dose and BSS in cirrhosis.
Flexible CO2 Laser in Therapeutic Bronchoscopy
ORTIZ-JAIMES, GABRIEL E, Mullon, John J., Nelson, Darlene R. , Reisenauer, Janani , Midthun, David E. , Edell, Eric S. , Anderson, Dagny , Vargas-Brochero, Maria J. , Petrossian, R., Kern, Ryan , Vargas-Brochero, Maria, Kern, R

Journal of Bronchology & Interventional Pulmonology | December 28, 2023 | Volume: 31 | Issue: 2 | Pages: 205-214

10.1097/lbr.0000000000000962 | PMID 38151967 Get It

Background: CO2 Laser (CO2L) technology deployable through flexible endoscopes now allows for their use throughout the airway, although published data are limited. Methods: Retrospective analysis of CO2L bronchoscopic procedures, excluding glottic and subglottic interventions. Procedural success was defined as >50% visual reduction in airway obstruction in the area treated or resolution of the procedural indication. Results: Seventy-two procedures were performed on 36 patients. Nonmalignant indications comprised 66%: stent-associated granulation tissue (28%), granulomatosis with polyangiitis lesions (23%), and lung transplant-related granulation tissue (16%) were the most common. Bronchoscopic access was flexible only in 81% and primarily rigid (combined with flexible) in 18%. The site of intervention was the trachea at 19%, the mainstem at 56%, and lobar/segmental airways at 45%. Procedural success was 89%. CO2L was used exclusively in 19%; in 81%, additional techniques were required, most commonly balloon dilation (59%), cryo-debulking (23%), and rigid dilation (16%). Malignant indications had a nonsignificant trend toward requiring adjuvant techniques (P=0.05). Seventy-six percent of the patients required more than 1 procedure. CO2L exclusive cases had no statistically different needs for subsequent therapeutic bronchoscopies (P=0.10) or time to reintervention (109 vs. 41 days, P=0.07), and reintervention-free survival was similar (P=0.10) and difficult to predict. The complication rate attributable to CO2L was 2.7%. Conclusion: CO2L is a safe and useful tool when precise cutting and vaporization are desired. Its use in multi-modality approaches has high levels of success in adequately selected lesions, adding an ablative potential to dilation techniques. Vasculitis-associated scars/webs and granulation tissue (including stent-associated) appear to be ideal targets.
How the United States syphilis epidemic may portend a resurgence of an unusual hematologic condition: The connection between syphilis and paroxysmal cold hemoglobinuria
Jacobs, Jeremy W. , Booth, Garrett S. , Adkins, Brian D. , Adkins, Brian David , Jacobs, Jeremy W , Booth, Garrett , Woo, Jennifer S. , Stephens, Laura D.

American Journal of Hematology | December 28, 2023 | Volume: 99 | Issue: 3 | Pages: 484-485

10.1002/ajh.27190 | PMID 38151909 Get It

Understanding Ventilator Operation: Importance of the Respiratory Therapist at the Bedside
LeTourneau, William M. , Oeckler, Richard A.

Respiratory Care | December 28, 2023 | Volume: 69 | Issue: 1 | Pages: 154-155

10.4187/respcare.11681 | PMID 38449087 Get It

Challenges in recognising paroxysmal cold hemoglobinuria
Jacobs, Jeremy W. , Booth, Garrett S. , Villalba, Cristina A. Figueroa , Adkins, Brian D. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Woo, Jennifer S. , Stephens, Laura D.

Transfusion Medicine | December 28, 2023 | Volume: 34 | Issue: 1 | Pages: 71-73

10.1111/tme.13024 | PMID 38151804 Get It

Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population
Jacobs, Jeremy W. , Adkins, Brian D. , Booth, Garrett S. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Stephens, Laura D. , Woo, Jennifer S.

Transfusion Medicine | December 28, 2023 | Volume: 34 | Issue: 3 | Pages: 234-235

10.1111/tme.13023 | PMID 38151773 Get It

Advances in MRI-Based Assessment of Rectal Cancer Post-Neoadjuvant Therapy: A Comprehensive Review
Miranda, João , Andrieu, Pamela Causa , Ninčević, Josip , Khasawneh, Hala , Arita, Yuki , Stanietzky, Nir , Fernandes, Maria Clara , Castria, Tiago Biachi De , Horvat, Natally , Causa Andrieu, Pamela , Khasawneh, Hala , Arita, Yuki , Fernandes, Maria Clara , Biachi de Castria, Tiago , Horvat, Natally , Farias, Lucas de Pádua Gomes de

Journal of Clinical Medicine | December 28, 2023 | Volume: 13 | Issue: 1 | Pages: 172

10.3390/jcm13010172 | PMID 38202179 Get It

Rectal cancer presents significant diagnostic and therapeutic challenges, with neoadjuvant therapy playing a pivotal role in improving resectability and patient outcomes. MRI serves as a critical tool in assessing treatment response. However, differentiating viable tumor tissue from therapy-induced changes on MRI remains a complex task. In this comprehensive review, we explore treatment options for rectal cancer based on resectability status, focusing on the role of MRI in guiding therapeutic decisions. We delve into the nuances of MRI-based evaluation of treatment response following neoadjuvant therapy, paying particular attention to emerging techniques like radiomics. Drawing from our insights based on the literature, we provide essential recommendations for post-neoadjuvant therapy management of rectal cancer, all within the context of MRI-based findings.
TREM2‐IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke
Yang, Sheng , Qin, Chuan, Chu, Yun‐Hui, Tang, Yue , Zhou, Luo‐Qi , Zhang, Hang , Dong, Ming‐Hao , Pang, Xiao‐Wei, Chen, Lian , Wu, Long‐Jun , Wang, Wei , Wang, Wei , Wu, Long-Jun , Qin, Chuan, Chen, Man , Tian, Dai‐Shi

Advanced Science | December 27, 2023 | Volume: 11 | Issue: 10 | Pages: No page available

10.1002/advs.202305614 | PMID 38151703 Get It

Abstract Microglia, the major resident immune cells in the central nervous system, serve as the frontline soldiers against cerebral ischemic injuries, possibly along with metabolic alterations. However, signaling pathways involved in the regulation of microglial immunometabolism in ischemic stroke remain to be further elucidated. In this study, using single‐nuclei RNA sequencing, a microglial subcluster up‐regulated in ischemic brain tissues is identified, with high expression of Igf1 and Trem2, neuroprotective transcriptional signature and enhanced oxidative phosphorylation. Microglial depletion by PLX3397 exacerbates ischemic brain damage, which is reversed by repopulating the microglia with high Igf1 and Trem2 phenotype. Mechanistically, Igf1 serves as one of the major down‐stream molecules of Trem2, and Trem2‐Igf1 signaling axis regulates microglial functional and metabolic profiles, exerting neuroprotective effects on ischemic stroke. Overexpression of Igf1 and supplementation of cyclocreatine restore microglial glucometabolic levels and cellular functions even in the absence of Trem2. These findings suggest that Trem2‐Igf1 signaling axis reprograms microglial immunometabolic profiles and shifts microglia toward a neuroprotective phenotype, which has promising therapeutic potential in treating ischemic stroke.
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce
Willis, Zachary , Oliveira, Carlos R. , Abzug, Mark J., Anosike, Brenda I. , Ardura, Monica I. , Bio, Laura , Boguniewicz, Juri , Downes, Kevin J. , Grapentine, Steven P, Hersh, Adam L. , Heston, Sarah M. , Hijano, Diego R. , James, Scott H. , Jones, Sarah Bruyn, Lockowitz, Christine R , Lloyd, Elizabeth C , MacBrayne, Christine E. , Marón, Gabriela , Hayes, Molly , Miller, Christine M , Morton, Ted , Olivero, Rosemary , Schwenk, Hayden T. , Soma, Vijaya L, Vora, Surabhi B , Nakamura, Mari , Wolf, Joshua , Willis, Zachary I , Bio, Laura L , Downes, Kevin J , Heston, Sarah M , Hijano, Diego R , Hayes McDonough, Molly , Miller, Christine M , Schwenk, Hayden T , Nakamura, Mari M , Wolf, Joshua , Boguniewicz, Juri , Oliveira, Carlos R , Chiotos, Kathleen , Huskins, W. Charles , Jones, Sarah, Orscheln, Rachel C. , Singh, Prachi , Sue, Paul K.

Journal of the Pediatric Infectious Diseases Society | December 27, 2023 | Volume: 13 | Issue: 3 | Pages: 159-185

10.1093/jpids/piad116 | PMID 38339996 Get It

Abstract Background Since November 2019, the SARS-CoV-2 pandemic has created challenges for preventing and managing COVID-19 in children and adolescents. Most research to develop new therapeutic interventions or to repurpose existing ones has been undertaken in adults, and although most cases of infection in pediatric populations are mild, there have been many cases of critical and fatal infection. Understanding the risk factors for severe illness and the evidence for safety, efficacy, and effectiveness of therapies for COVID-19 in children is necessary to optimize therapy. Methods A panel of experts in pediatric infectious diseases, pediatric infectious diseases pharmacology, and pediatric intensive care medicine from 21 geographically diverse North American institutions was re-convened. Through a series of teleconferences and web-based surveys and a systematic review with meta-analysis of data for risk factors, a guidance statement comprising a series of recommendations for risk stratification, treatment, and prevention of COVID-19 was developed and refined based on expert consensus. Results There are identifiable clinical characteristics that enable risk stratification for patients at risk for severe COVID-19. These risk factors can be used to guide the treatment of hospitalized and non-hospitalized children and adolescents with COVID-19 and to guide preventative therapy where options remain available.
Comparative analysis of syringes versus pump devices in benchtop aspiration thrombectomy models: A systematic review and meta-analysis
Şenol, Yiğit Can , Orscelik, Atakan , Kobeissi, Hassan , Bilgin, Cem , Ghozy, Sherief , Kadirvel, Ramanathan , Kallmes, David F. , Orscelik, Atakan , Kobeissi, Hassan , Bilgin, Cem , Oliver, Alexander A , Ghozy, Sherief , Kadirvel, Ram , Kallmes, David F , Senol, Yigit Can , Li, Jiahui

Interventional Neuroradiology | December 27, 2023 | Volume: 32 | Issue: 3 | Pages: 891-897

10.1177/15910199231222305 | PMID 38151033 Get It

Background Although direct contact aspiration has emerged as one of the leading techniques for mechanical thrombectomy (MT), there is still ongoing debate about the aspiration/suction pump devices that can optimize recanalization rates. To address this gap, we conducted a meta-analysis comparing the aspiration efficacy of 60 ml syringe and pump devices in benchtop MT models. Methods Systematic literature review was conducted using Medline, Embase, Web of Science, and Scopus in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Outcomes of interest included flow rate and vacuum pressure delivered by a 60 ml syringe and several aspiration pumps. We used a random effects model to calculate the mean difference (MD) with 95% confidence intervals (CIs) and a statistically significant difference was considered as a two-sided p -value of less than 0.05. Results We included six benchtop studies comparing 60 ml syringes and vacuum pumps. Our meta-analysis showed that there were no significant differences in vacuum pressure (MD:0.71inHg, 95% CI: [−0.81;2.23], p = 0.359) and flow rate (MD:0.27 mL/s, 95% CI: [−3,07; 3.61], p = 0.873) between 60 ml syringes and vacuum pumps groups. Conclusions Our study demonstrated comparable performance in terms of vacuum pressure and flow rates between a 60 ml syringe and a heterogeneous combination of commercially available aspiration pumps.